
|Videos|January 31, 2019
Treating An Elderly Woman with Chronic Lymphocytic Leukemia
Treating An Elderly Woman with Chronic Lymphocytic Leukemia
Advertisement
An Elderly Woman With CLL
- A 78-yearold female presented with symptoms of fatigue and loss of appetite for the past six months
- PMH: recurrent bronchitis during past 12 months, treated with antibiotics
- PE: vital signs WNL, right cervical lymphadenopathy, spleen palpable 5 cm below costal margin, otherwise well-appearing
- Laboratory findings:
- WBC, 53,000; 76% lymphocytes
- Hb; 10.4 g/dL
- Platelets; 150 X 109/L
- ANC; 180/mm3
- Flow cytometry; CD5+, CD19+, CD23+
- Cytogenetics, FISH: trisomy 12; IgVH mutated
- β2M, 3.6 mg/L
- BM biopsy; diffuse infiltration by CLL
- Diagnosis; chronic lymphocytic leukemia
- The patient was treated with ibrutinib and achieved a complete response to therapy after 4 months
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5









































